This announcement is a separate document:
赛隆药业：第四届董事会审计委员会2024年第三次会议的审查意见
Sailong Pharmaceutical: Review Opinions of the Third Meeting of the Fourth Board Audit Committee in 2024
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated